Specialties

Addressing the gaps in lipoprotein cholesterol (LDL-C) control and statin prescribing among patients with type 2 diabetes.

In addition to clinical trials, does data from a meta-analysis of retrospective cohort studies support the benefits of SGLT-2 inhibitors?

Despite being on first-line oral anti-diabetic drug therapy, the risk of developing CVD/CKD in patients with type 2 diabetes remains high.

Examining how curcumin and other bioactive compounds in turmeric lower blood glucose.

Sodium-glucose cotransporter 2 (SGLT2) inhibitors were created to treat diabetes, but noted to ameliorate cardiovascular events. 

Artificial intelligence fingerprints gut flora, linking clusters of microbial species with type 1 diabetes development.

DPP4 inhibitors may restore the normal functioning of vascular endothelium in patients who require insulin treatment. 

Researchers showed that elevated blood pressure is a modifiable risk factor for new-onset type 2 diabetes.

Risk factors associated with diabetic foot ulcers (DFU) are easily found in medical records, giving clinicians a tool for early detection.

A prospective study found an increased risk for fractures and falls among older women with type 2 diabetes.